Establishment and characterization of cisplatin-resistant human epidermoid carcinoma cell line, A431 cell

Chemotherapy

Volumn 44, Issue 6, 1998, Pages 414-420

  Mese, Hiroshi ^a   Sasaki, Akira ^a   Alcalde, Rafael E ^a   Nakayama, Shuko ^a   Matsumura, Tomohiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

A431; Cisplatin resistance; Nude mice; Oral cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; MUTAGENIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CROSS RESISTANCE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0031698225     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007153     Document Type: Article

References (29)

1. Durant JR: Cisplatin: A clinical overview, in Prestayko AW, Crooke ST, Carter SK (eds): Cisplatin, Current Status and New Developments. New York, Academic Press, 1980, pp 317-321.
2. Hamasaki VK, Vokes EE: Chemotherapy in head and neck cancer. Curr Opin Oncol 1992;4:1376-1384.
3. Adelstein DJ, Sharan VM, Earle AS, Shah AC, Vlastou C, Haria CD, Carter SG, Damm C, Hines D: Long-term results after chemoradiotherapy for locally confined squamous-cell head and neck cancer. J Clin Oncol 1990;13:440-447.
4. Weissler MC, Melin S, Sailer SL, Qaqish BF, Rosenman JG, Pillsbury HC III: Simultaneous chemoradiotherapy in treatment of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1992;118: 806-810.
5. Andrew PA, Howell SB: Cellular pharmacology of cisplatin: Perspectives on mechanisms of acquired resistance. Cancer Cells 1990;2:35-43.
6. Scanlon KJ, Kashani-Sabet M, Tone T, Funato T: Cisplatin resistance in human cancers. Pharmacol Ther 1991;52:385-406.
7. Hamilton TC, O'Dwyer PJ, Ozols RF: Platinum analogues in preclinical and clinical development. Curr Opin Oncol 1993;5:385-406.
8. Gately DP, Howell SB: Cellular accumulation of the anticancer agent cisplatin a review. Br J Cancer 1993; 67:1171-1176.
9. Saburi Y, Nakagawa M, Ono M, Sakai M, Muramatsu M, Kohno K, Kuwano M: Increased expression of glutation-S-transferase gene in cis-diamminedichloroplatinum (II) -resistant variants of a Chinese hamster ovary cell line. Cancer Res 1989;49:7020-7025.
10. Misty P, Kelland LR, Abel G, Sidhar S, Harrap KR: The relationships between glutathione glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines. Br J Cancer 1991;64:215-220.
11. Tew KD: Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 1994;54:4313-4320.
12. Kasahara K, Fujiwara Y, Nishio K, Ohmori T, Sugimoto Y, Komiya K, Matsuda T, Saijo N: Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res 1991;63:3237-3242.
13. Yang YY, Woo ES, Reese CE, Bahnson RR, Saijo N, Lazo JS: Human metallothionein isoform gene expression in cisplatin sensitive and resistant cells. Mol Pharmacol 1994; 45:453-460.
14. Fink D, Nebel S, Aebi S, Zheng H, Cenni B, Nehme A, Christen RD, Howell SB: The role of DNA mismatch repair in platinum drug resistance. Cancer Res 1996;56:4881-4886.
15. Fink D, Zheng H, Nebel S, Norris PS, Aebi S, Lin TP, Nehme A, Christen RD, Haas M, MacLeod CL, Howell SB: In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair. Cancer Res 1997;57:1841-1845.
16. Simmonds AP, McDonald EC: Ovarian carcinoma cells in culture: Assessment of drug sensitivity by clonogenic assay. Br J Cancer 1984; 50:317-326.
17. Wolf CR, Hayward IP, Lawrie SS, Buckton K, McIntyre MA, Adams DJ, Lewis AD, Scott ARR, Smyth JF: Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient. Int J Cancer 1987;39: 695-702.
18. Miyasita T, Reed JC: Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in human leukemia cell line. Blood 1993;81:151-157.
19. Eliopoulos AG, Kerr D, Herod J, Hodgkins L, Krajewski S, Reed JC, Young LS: The control of apoptosis and drug resistance in ovarian cancer: Influence of p53 and Bcl-2. Oncogene 1995;11:1217-1228.
20. Teicher BA, Holden SA, Kelly MJ, Shea TC, Cucchi CA, Rosowsky A, Henner WD, Frei E III: Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II). Cancer Res 1987;47:388-393.
21. Pera MF Jr, Harder HC: Analysis for platinum in biological material by flameless atomic absorption spectrometry. Clin Chem 1977;23: 1245-1249.
22. Funayama T, Nakanishi T, Takahashi K, Taniguchi S, Takigawa M, Matsumura T: Overexpression of c-erbB-3 in various stages of human squamous cell carcinoma. Oncology 1998;55:161-167.
23. Belvedere G, Imperatori L, Damia G, Tagliabue G, Meijer C, de Vries EGE, D'Incalci M: In vitro and in vivo characterisation of low-resistant mouse reticulosarcoma (M5076) sublines obtained after pluse and continuous exposure to cisplatin. Eur J Cancer 1996;32A: 2011-2018.
24. Rosenberg B: Antitumor activity of cis-dichlorodiammineplatinum (II) and some relevant chemistry. Cancer Treat Rep 1979;63:1433-1438.
25. Zwelling LA, Kohn KW: Mechanism of action cis-dichlorodiammineplatinum(II). Cancer Treat Rep 1979;63:1439-1444.
26. Rosenberg B: Fundamental studies with cis-platin. Cancer 1985;55: 2303-2316.
27. Bosscha HT, Mulder NH, de Vries EGE: Modulation of cis-diamminedichloroplatinum(II) resistance: A review. Br J Cancer 1992;66:227-238.
28. Bungo M, Fujiwara Y, Kasahara K, Nakagawa K, Ohe Y, Sasaki Y, Irino S, Saijo N: Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum (II) in human non-small cell lung cancer cell lines: Relation to DNA damage and repair. Cancer Res 1990;50: 2549-2553.
29. Kawai K, Kamatani N, Georges E, Ling V: Identification of a membrane glycoprotein overexpressed in murine lymphoma sublines resistant to cis-diamminedichloroplatinum (II). J Biol Chem 1990;265: 13137-13142.